Based on the iShares Biotechnology ETF stock forecast from 0 analysts, the average analyst target price for iShares Biotechnology ETF is not available over the next 12 months. iShares Biotechnology ETF’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of iShares Biotechnology ETF is Neutral, which is based on 3 positive signals and 3 negative signals. At the last closing, iShares Biotechnology ETF’s stock price was USD 133.61. iShares Biotechnology ETF’s stock price has changed by -2.65% over the past week, -3.15% over the past month and -0.12% over the last year.
No recent analyst target price found for iShares Biotechnology ETF
No recent average analyst rating found for iShares Biotechnology ETF
Company Overview iShares Biotechnology ETF
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified. Read Less
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.
Frequently Asked Questions About iShares Biotechnology ETF (IBB) Stock
Stock Target Advisor's fundamental analysis for iShares Biotechnology ETF's stock is Neutral.
IBB stock's dividend yield is 0.32%.
Our analysis grades IBB stock's dividend yield at D-. This means that IBB stock's dividend yield is above 60% of the stocks in the Health sector in the NSD exchange.
Based on this IBB may be a average dividend stock for its sector.
Unfortunately we do not have enough data on IBB's stock to indicate what its average analyst target is.
IBB stock's Price/Earning ratio is 17.30.
Our analysis grades IBB stock's Price / Earning ratio at B-. This means that IBB stock's Price/Earning ratio is above 20% of the stocks in the Health sector in the NSD exchange.
Based on this IBB may be undervalued for its sector.
The last closing price of IBB's stock was USD 133.61.
The most recent market capitalization for IBB is USD 6.91B.
Unfortunately we do not have enough analyst data on IBB's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains iShares Biotechnology ETF's stock.
Sorry, we do not have any data on the number of employees for iShares Biotechnology ETF.
Sorry we do not have any infomation available on iShares Biotechnology ETF's address.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Underpriced compared to earnings
The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Below median total returns
The company has under performed its peers on annual average total returns in the past 5 years.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Frequently Asked Questions About iShares Biotechnology ETF (IBB) Stock
Stock Target Advisor's fundamental analysis for iShares Biotechnology ETF's stock is Neutral.
IBB stock's dividend yield is 0.32%.
Our analysis grades IBB stock's dividend yield at D-. This means that IBB stock's dividend yield is above 60% of the stocks in the Health sector in the NSD exchange.
Based on this IBB may be a average dividend stock for its sector.
Unfortunately we do not have enough data on IBB's stock to indicate what its average analyst target is.
IBB stock's Price/Earning ratio is 17.30.
Our analysis grades IBB stock's Price / Earning ratio at B-. This means that IBB stock's Price/Earning ratio is above 20% of the stocks in the Health sector in the NSD exchange.
Based on this IBB may be undervalued for its sector.
The last closing price of IBB's stock was USD 133.61.
The most recent market capitalization for IBB is USD 6.91B.
Unfortunately we do not have enough analyst data on IBB's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains iShares Biotechnology ETF's stock.
Sorry, we do not have any data on the number of employees for iShares Biotechnology ETF.
Sorry we do not have any infomation available on iShares Biotechnology ETF's address.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for IBB !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
